about
Gene therapy for mucopolysaccharidosisPreferential delivery of the Sleeping Beauty transposon system to livers of mice by hydrodynamic injectionProgress and prospects: zinc-finger nucleases as gene therapy agentsNeuroprotective therapies in glaucoma: II. Genetic nanotechnology toolsArchitecture of a Serine Recombinase-DNA Regulatory ComplexThe therapeutic potential of ΦC31 integrase as a gene therapy systemConditional gene manipulation: Cre-ating a new biological eraImpact of hydrodynamic injection and phiC31 integrase on tumor latency in a mouse model of MYC-induced hepatocellular carcinomaNonviral gene delivery: principle, limitations, and recent progress.Regenerating cochlear hair cells: quo vadis stem cell.Stem cells and molecular strategies to restore hearingPhiC31 integrase induces a DNA damage response and chromosomal rearrangements in human adult fibroblasts.Effect of nuclear localization and hydrodynamic delivery-induced cell division on phiC31 integrase activityMutational derivatives of PhiC31 integrase with increased efficiency and specificity.PhiC31 integrase induces efficient site-specific recombination in the Capra hircus genome.Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells.Treatment of mouse limb ischemia with an integrative hypoxia-responsive vector expressing the vascular endothelial growth factor gene.Kinetics and longevity of ΦC31 integrase in mouse liver and cultured cellsGeneration of induced pluripotent stem cells using site-specific integration with phage integraseAdeno-associated virus: a key to the human genome?DNA lesion identity drives choice of damage tolerance pathway in murine cell chromosomes.Targeted plasmid integration into the human genome by an engineered zinc-finger recombinaseMeganucleases and other tools for targeted genome engineering: perspectives and challenges for gene therapy.Adjusting the attB site in donor plasmid improves the efficiency of ΦC31 integrase systemRegulated gene insertion by steroid-induced PhiC31 integrase.Conservative site-specific and single-copy transgenesis in human LINE-1 elements.Recent advances in gene therapy for severe congenital immunodeficiency diseasesSite-directed zebrafish transgenesis into single landing sites with the phiC31 integrase system.Regulatory mutations in Sin recombinase support a structure-based model of the synaptosome.Integration-deficient lentiviral vectors: a slow coming of age.Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.Targeted approaches for gene therapy and the emergence of engineered meganucleases.ΦC31 integrase mediates efficient cassette exchange in the zebrafish germline.Recombinase technology: applications and possibilitiesEx vivo gene transfer and correction for cell-based therapies.Regenerative nanomedicine and the treatment of degenerative retinal diseases.Cutting out the φC31 prophage.Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system.α- L-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice.Construction of transformed, cultured silkworm cells and transgenic silkworm using the site-specific integrase system from phage φC31.
P2860
Q24631135-56480B15-85C9-4542-9A3C-A3F59323E66CQ24646028-9E0461B6-773E-4DEE-9925-8D0BC95F5298Q24650545-08C3E50E-8261-415D-BA90-BA823C78FA35Q26777286-18C278CB-95F7-4837-87AA-D01162D8840EQ27650461-34BDB08B-98B1-4AC6-BA40-D7E61AA3C243Q28242655-354A97F6-2B4D-48CA-AD9A-12E510F465F8Q28270282-C23FF5C7-E31C-4AEC-9E85-A0E9EDE52274Q28750796-F7AF76EE-A1A0-4FA5-A79F-BA77BE6EA145Q30479098-BF66396C-128B-425E-9E5A-4645A52408FBQ30490921-CE14C5C4-7197-4AB0-A56F-4F1407B2E0DCQ30491016-1CE00C01-CBE6-4D10-A0C3-E342742E99ADQ33426087-1A47DFB8-EA6D-4BE4-B0B3-90B86DAE3F77Q33647678-9F8F7B58-1D9D-43FC-89EF-695F4B55608EQ33713025-514821AA-9005-4824-B79C-549B48C799A6Q33980722-BB03FAA5-E826-4BA1-B92B-CC23B4D0C5EBQ34025078-ED762EA3-0611-455E-B95C-55413325E9B3Q34217612-AB9AA7E2-3865-458E-AB2C-7C37D5CD424AQ34283639-A634A191-E92F-44BB-9E53-6C96CBD5ED70Q34320340-4927E616-0C94-4BF9-B1A6-92E668119241Q34459999-101E07EA-9244-4F9F-B99C-18B091306FBBQ35088992-AF492991-592B-49E0-8431-0A9A4A368F86Q35224339-FFFC328C-11C2-470A-90D3-625949AF0D6FQ35701287-E2694597-AFC1-41CB-BF3B-0C1B8961BB4AQ36081378-522AFF14-849E-43A4-82AF-D3E91E290D1CQ36740084-3B7D6DE2-65A9-4CEF-8B36-4D4EF29ED73AQ36775486-B8B0A405-9719-4BEF-B228-54BA7E9A04A8Q37153580-42B8398B-52B7-4F08-B9BA-DE0233C62F4AQ37177674-EBF9AFFD-9948-4D11-AFCC-30764E799BF4Q37392669-6E6E95B2-5F49-48C3-9CF6-B7E196E296DAQ37506025-4BB726A0-59B6-4877-8F36-785EE60E8BCCQ37526991-9E7F2A29-884F-4D2B-9393-97069148468DQ37581606-386D0B07-85D0-44FC-971B-BC8B535B36A0Q37609161-0C644FD1-9A40-4ADD-AF82-AF3A86CB6E5FQ37802791-737D21CE-6D88-4661-B660-A8D087B0D351Q37858878-13944157-72D3-438C-840C-03F333B38A67Q37968572-3548137D-E547-4EEC-9BEA-D834D778E9D2Q38427991-5B2EE61F-B9B8-426F-BBD7-50966BEA8985Q38892183-379567FD-6C79-4022-B973-AB2C3A78212FQ38918949-41871CF5-390A-4659-80EB-C4F17CC6E9FEQ38978531-0394513C-C2FF-48BC-84C4-B036A43BB993
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The phiC31 integrase system for gene therapy.
@ast
The phiC31 integrase system for gene therapy.
@en
type
label
The phiC31 integrase system for gene therapy.
@ast
The phiC31 integrase system for gene therapy.
@en
prefLabel
The phiC31 integrase system for gene therapy.
@ast
The phiC31 integrase system for gene therapy.
@en
P1433
P1476
The phiC31 integrase system for gene therapy.
@en
P2093
Michele P Calos
P304
P356
10.2174/156652306779010642
P407
P577
2006-12-01T00:00:00Z